Avio Smart Market signs deal with Huwel for RT-PCR expansion
- Avio Smart Market Stack partners with Huwel Lifesciences to commercialise the Cubo RT-PCR system in India
- The collaboration involves building dedicated sales infrastructure and recruiting senior sales leadership
- Target customers include private hospitals, diagnostic chains, independent labs, and medical colleges
- The partnership aims to decentralise RT-PCR testing beyond centralised laboratories to Tier-II and Tier-III cities

*this image is generated using AI for illustrative purposes only.
Avio Smart Market Stack has entered into a partnership with Huwel Lifesciences to expand access to compact RT-PCR testing across India.
Partnership details
The collaboration aims to broaden the reach of compact RT-PCR testing solutions throughout the country. As part of the initiative, the two companies plan to develop sales infrastructure and a distribution network to support wider deployment of the technology. Specifically, they will establish a dedicated sales and distribution infrastructure, including the recruitment of senior sales leadership, formation of specialised sales teams, and development of strategic channel partnerships.
| Parameter | Details |
|---|---|
| Partner | Huwel Lifesciences |
| Focus area | Compact RT-PCR testing (Cubo system) |
| Geographic scope | India |
| Initiative components | Sales infrastructure, distribution network, senior leadership recruitment |
The partnership reflects an effort to make RT-PCR testing more accessible across diverse geographies within India through a structured commercial and logistical framework.
Commercial strategy and product focus
The initiative will initially focus on Cubo, Huwel's ultra-compact RT-PCR system, while creating opportunities to commercialise Huwel's broader molecular diagnostics portfolio. The commercialisation strategy targets private hospitals, diagnostic chains, independent laboratories, medical colleges, research institutions, and other healthcare establishments.
Cubo is designed to enable RT-PCR testing beyond conventional centralised laboratory environments. Its ultra-compact design allows molecular diagnostic capabilities to be considered for smaller and more decentralised healthcare settings, potentially reducing dependence on large centralised facilities. This approach is particularly relevant to India's healthcare landscape, which spans metropolitan centres as well as a large and geographically distributed network of Tier-II and Tier-III cities, hospitals, and diagnostic facilities.
Beyond instrument deployment, Avio Smart Market Stack and Huwel intend to develop an ecosystem around the platform, comprising compatible molecular assays and consumables that can support recurring testing requirements. Huwel's capabilities across molecular diagnostic applications could enable Cubo installations to serve multiple testing needs rather than being limited to a single application.
Leadership commentary
N Vidhya Sagar Reddy, Managing Director of Avio Smart Market Stack, stated that the next phase of the collaboration is focused on building the commercial infrastructure needed to take advanced molecular diagnostic technologies to a much wider customer base. He noted that Cubo's compact format creates an opportunity to bring RT-PCR capabilities closer to hospitals, laboratories, and other healthcare providers, including those outside the traditional centralised laboratory ecosystem.
The proposed sales organisation will work across direct sales and channel partnerships, supported by product demonstrations, installation support, and ongoing customer engagement. For Avio Smart Market Stack, the initiative represents an opportunity to build its presence in healthcare and diagnostics through indigenous technologies, while Huwel gains additional commercial reach and execution capabilities to support the wider adoption of its products.
Historical Stock Returns for Avio Smart Market Stack
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.32% | -6.81% | -12.13% | -13.60% | -56.22% | -53.33% |
How will the distribution network for Cubo systems specifically address logistical challenges in India's Tier-II and Tier-III cities?
What regulatory approvals or compliance milestones must Huwel Lifesciences secure to expand its broader molecular diagnostics portfolio in the Indian market?
How does this partnership impact Avio Smart Market Stack's revenue diversification strategy as it enters the healthcare diagnostics sector?


































